Applovin Corporation Other Non-Current Liabilities increased by 20.7% to $335.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.3%, from $212.09M to $335.82M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 36.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $199.71M | $152.05M | $112.82M | $113.83M | $132.57M | $141.49M | $106.68M | $159.12M | $143.09M | $132.98M | $209.93M | $249.90M | $242.87M | $250.29M | $180.47M | $212.09M | $187.53M | $284.02M | $278.16M | $335.82M |
| QoQ Change | — | -23.9% | -25.8% | +0.9% | +16.5% | +6.7% | -24.6% | +49.2% | -10.1% | -7.1% | +57.9% | +19.0% | -2.8% | +3.1% | -27.9% | +17.5% | -11.6% | +51.5% | -2.1% | +20.7% |
| YoY Change | — | — | — | — | -33.6% | -6.9% | -5.4% | +39.8% | +7.9% | -6.0% | +96.8% | +57.1% | +69.7% | +88.2% | -14.0% | -15.1% | -22.8% | +13.5% | +54.1% | +58.3% |